Close
Smartlab Europe
Achema middle east

News

Draft Pandemic Accord Has IP Waivers, Pathogen Sharing Perks

The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important elements. One of these is the provision for time-bound waivers when it comes to intellectual...

Greater Pharma & Tech COs Ties Can Drive Innovation Further

Big tech along with Big Pharma have gone on to play a crucial role in elevating standards of living as well as shaping the modern age. Over the course of several decades, both big pharma and big tech have heavily relied on...

CDMO-Biotech Collab Diminish Business Risk In Drug Creation

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high costs, complicated manufacturing processes, as well as regulatory hurdles related to biologics can go on...

Medical Drone Delivery Segment To Be Kept Close Eyes On

The healthcare industry is experiencing prominent changes because of the rapid advancement of tech. Artificial intelligence- AI is already playing a pivotal role in drug delivery and is also utilised across the manufacturing sector. Digital health has quickly emerged...

How To Get Off Drugs Safely

Dealing with drug and substance abuse can cause a lot of issues. Many people struggle with drug addiction, whether this is to illegal or legal substances, which can ruin their health and wellbeing. Addiction is not something you can deal...

Workforce Training To Improve APAC Response To The Pandemic

The Ministry of Health and Welfare in South Korea has gone on to announce a collaborative effort with the Asian Development Bank to carry out a joint training programme. The idea of this programme is to boost vaccine manufacturing capacity...

MHRA Rolls Out New Scheme For Lowest-Risk UK Clinical Trials

The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to clinical trials in the UK that are at lowest risk by more than 50%.  The novel...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »